NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » Articles posted by murthyvittala
 

All articles by  

Cepheid Q2 Revenues Raise 10%

Cepheid has posted a net loss of $1.8m or $(0.03) per diluted share, for the second quarter of 2010, when compared to revenues of $41.0m and a net

MannKind Presents Afrezza Insulin Therapy Data

MannKind said that Afrezza is a drug-device combination product, consisting of Afrezza inhalation powder pre-metered into single use dose cartridges and the light, discreet and easy-to-use Afrezza Inhaler.